Showing results (451-460 of 2,911) with videos related to

Sort By:
Pageof 292
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic SclerosisHenriette Didriksen, Øyvind Molberg, Håvard Fretheim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung DiseaseJorge A Zamora-Legoff, Megan L Krause, Cynthia S Crowson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2016
Discovery of T Cell Receptor β Motifs Specific to HLA-B27-Positive Ankylosing Spondylitis by Deep Repertoire Sequence AnalysisMalek Faham, Victoria Carlton, Martin Moorhead, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 26, 2016
Role of Fibulin 3 in Aging-Related Joint Changes and Osteoarthritis Pathogenesis in Human and Mouse Knee CartilageAkihiko Hasegawa, Tomo Yonezawa, Noboru Taniguchi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2016
Rheumatoid Arthritis and Risk of Malignant Lymphoma: Is the Risk Still Increased?K Hellgren, E Baecklund, C Backlin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2016
Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double-Blind, Randomized, Parallel-Group TrialN Yokogawa, H Eto, A Tanikawa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 9, 2019
Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up StudyNienke M Ter Haar, E H Pieter van Dijkhuizen, Joost F Swart, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 17, 2019
Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus ErythematosusAlexandra Legge, Susan Kirkland, Kenneth Rockwood, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptorSeung Y Chu, Karen Yeter, Roshan Kotha, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiationYukari Saito, Shin-Ichiro Kagami, Yoshie Sanayama, et al.
Pageof 292